Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial.
Health Aff (Millwood)
; 27(2): w96-104, 2008.
Article
en En
| MEDLINE
| ID: mdl-18216044
ABSTRACT
Current influenza vaccination recommendations focus on immunizing high-risk people; however, influenza mortality and morbidity remain elevated. U.S. policymakers are considering expansion of flu vaccination recommendations to include school-age children (ages 5-18). Children are at risk for flu and propagate epidemic spread. Immunizing children at school offers an efficient approach to covering this population. This study examines the cost consequences of a large multistate, school-based influenza immunization program. The results show that immunization reduces disease among children and adults and is cost-saving to society. An epidemiologically based influenza immunization policy might be an important supplement to the existing risk-based policy.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Servicios de Salud Escolar
/
Vacunas contra la Influenza
/
Programas de Inmunización
Tipo de estudio:
Clinical_trials
/
Evaluation_studies
/
Health_economic_evaluation
Límite:
Adolescent
/
Child
/
Child, preschool
/
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
Health Aff (Millwood)
Año:
2008
Tipo del documento:
Article
País de afiliación:
Estados Unidos